trending Market Intelligence /marketintelligence/en/news-insights/trending/4vYxYrp33Q7Rxdn2hKw2Sg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Apotheca Biosciences appoints chairman/CEO


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Apotheca Biosciences appoints chairman/CEO

Apotheca Biosciences Inc. appointed P.C. Sundareswaran as chairman and CEO, effective Jan. 1, 2019.

The Saint Petersburg, Fla.-based company said Sam Talari had resigned as CEO and director on Dec. 4. Apotheca said Talari's decision was based on personal matters and not related to any disagreement with the company.

The company's Chief Technology Officer John Verghese will act as CEO until Sundareswaran assumes the role.

In addition, Apotheca COO Deidre Fernandes was elected as a board member, effective Dec. 4.

Apotheca develops nutraceuticals, formulations, and delivery technologies for the healthcare and consumer care industry.